Latest Breaking News On - Moderate to severe atopic - Page 1 : comparemela.com

Children with Atopic Dermatitis May Be Shorter in Height

New global data suggest children with moderate to severe atopic dermatitis may experience stunted growth due to the effect of their disease on sleep, as well as use of certain therapies.

San diegoUnited statesAmys pallerNational centerVital health statAmerican academy of dermatologyHealth statisticsAmerican academyObservational evaluationAtopic dermatitisPediatric patientsChildren aged less thanModerate to severe atopic

Almirall, S A : Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business

Almirall, S A : Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomComunidad autonoma de catalunaStefan klotterAstra zeneca covisCarlos gallardoAstrazeneca covisResearch developmentCorporate communicationsNovo nordiskRegulatory agencyChinese national medical products administrationSpanish stock exchangeEuropean commissionEuropean dermatologyNet sales

Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business

BARCELONA, February 19, 2024 Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its full-year 2023 financial results.

United statesUnited kingdomComunidad autonoma de catalunaAstra zeneca covisCarlos gallardoAstrazeneca covisResearch developmentCorporate communicationsRegulatory agencyNovo nordiskChinese national medical products administrationEuropean commissionSpanish stock exchangeEuropean dermatologyNet salesAstra zeneca

Positive Long-Term Data Shown in Patients with Atopic Dermatitis Treated with Rademikibart

These pivotal trial results from a study in China indicated the potential of this drug as a quarterly treatment for individuals with eczema.

Zheng weiBiopharma holdingsConnect biopharma holdings limitedConnect biopharmaBiopharma announces positive long term dataChina pivotal trialModerate to severe atopicAtopic dermatitis

Almirall S A : Almirall Receives European Commission Approval of EBGLYSS (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis

Almirall S A : Almirall Receives European Commission Approval of EBGLYSS (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomComunidad autonoma de catalunaRheinland pfalzVolker koscielnyEurope almirallStephan weidingerJ clin dermatolAndrew blauveltOmar ramEli lillyEuropean commissionClinical development programHead of the department dermatologyUniversity hospital schleswig holsteinCorporate communications